Axogen Statistics
Total Valuation
Axogen has a market cap or net worth of $1.18 billion. The enterprise value is $1.25 billion.
Important Dates
The last earnings date was Wednesday, October 29, 2025, before market open.
| Earnings Date | Oct 29, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Axogen has 46.12 million shares outstanding. The number of shares has increased by 5.77% in one year.
| Current Share Class | 46.12M |
| Shares Outstanding | 46.12M |
| Shares Change (YoY) | +5.77% |
| Shares Change (QoQ) | +2.31% |
| Owned by Insiders (%) | 2.28% |
| Owned by Institutions (%) | 93.08% |
| Float | 45.07M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 379.17 |
| PS Ratio | 5.41 |
| Forward PS | 4.86 |
| PB Ratio | 9.64 |
| P/TBV Ratio | 10.61 |
| P/FCF Ratio | 363.21 |
| P/OCF Ratio | 186.43 |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
The stock's EV/EBITDA ratio is 114.56, with an EV/FCF ratio of 373.38.
| EV / Earnings | n/a |
| EV / Sales | 5.81 |
| EV / EBITDA | 114.56 |
| EV / EBIT | 316.62 |
| EV / FCF | 373.38 |
Financial Position
The company has a current ratio of 4.09, with a Debt / Equity ratio of 0.58.
| Current Ratio | 4.09 |
| Quick Ratio | 2.38 |
| Debt / Equity | 0.58 |
| Debt / EBITDA | 4.80 |
| Debt / FCF | 20.89 |
| Interest Coverage | 0.51 |
Financial Efficiency
Return on equity (ROE) is -1.90% and return on invested capital (ROIC) is 1.36%.
| Return on Equity (ROE) | -1.90% |
| Return on Assets (ROA) | 1.21% |
| Return on Invested Capital (ROIC) | 1.36% |
| Return on Capital Employed (ROCE) | 2.09% |
| Revenue Per Employee | $475,020 |
| Profits Per Employee | -$4,639 |
| Employee Count | 452 |
| Asset Turnover | 1.05 |
| Inventory Turnover | 1.55 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +101.33% in the last 52 weeks. The beta is 1.09, so Axogen's price volatility has been similar to the market average.
| Beta (5Y) | 1.09 |
| 52-Week Price Change | +101.33% |
| 50-Day Moving Average | 19.38 |
| 200-Day Moving Average | 15.81 |
| Relative Strength Index (RSI) | 76.88 |
| Average Volume (20 Days) | 923,223 |
Short Selling Information
The latest short interest is 2.73 million, so 5.93% of the outstanding shares have been sold short.
| Short Interest | 2.73M |
| Short Previous Month | 2.48M |
| Short % of Shares Out | 5.93% |
| Short % of Float | 6.06% |
| Short Ratio (days to cover) | 2.89 |
Income Statement
In the last 12 months, Axogen had revenue of $214.71 million and -$2.10 million in losses. Loss per share was -$0.05.
| Revenue | 214.71M |
| Gross Profit | 160.52M |
| Operating Income | 3.94M |
| Pretax Income | -2.10M |
| Net Income | -2.10M |
| EBITDA | 10.89M |
| EBIT | 3.94M |
| Loss Per Share | -$0.05 |
Full Income StatementBalance Sheet
The company has $35.79 million in cash and $69.78 million in debt, giving a net cash position of -$33.99 million or -$0.74 per share.
| Cash & Cash Equivalents | 35.79M |
| Total Debt | 69.78M |
| Net Cash | -33.99M |
| Net Cash Per Share | -$0.74 |
| Equity (Book Value) | 120.81M |
| Book Value Per Share | 2.62 |
| Working Capital | 86.45M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $6.51 million and capital expenditures -$3.17 million, giving a free cash flow of $3.34 million.
| Operating Cash Flow | 6.51M |
| Capital Expenditures | -3.17M |
| Free Cash Flow | 3.34M |
| FCF Per Share | $0.07 |
Full Cash Flow StatementMargins
Gross margin is 74.76%, with operating and profit margins of 1.84% and -0.98%.
| Gross Margin | 74.76% |
| Operating Margin | 1.84% |
| Pretax Margin | -0.98% |
| Profit Margin | -0.98% |
| EBITDA Margin | 5.07% |
| EBIT Margin | 1.84% |
| FCF Margin | 1.56% |
Dividends & Yields
Axogen does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -5.77% |
| Shareholder Yield | -5.77% |
| Earnings Yield | -0.17% |
| FCF Yield | 0.28% |
Dividend DetailsAnalyst Forecast
The average price target for Axogen is $27.71, which is 7.95% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $27.71 |
| Price Target Difference | 7.95% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 7 |
| Revenue Growth Forecast (5Y) | 16.28% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Axogen has an Altman Z-Score of 3.82 and a Piotroski F-Score of 5.
| Altman Z-Score | 3.82 |
| Piotroski F-Score | 5 |
